BiotechTube
Home/Muvon Therapeutics/Deana Mohr
DM

Deana Mohr

Likely Founder/CEO (based on award)

Muvon Therapeutics

Therapeutic Areas

UrologyWomen's HealthRegenerative Medicine

Muvon Therapeutics Pipeline

DrugIndicationPhase
Autologous Muscle Precursor Cell TherapyStress Urinary Incontinence (SUI) in WomenPhase 2

Leadership Team at Muvon Therapeutics

DC
Dr. Christine Günther
Chief Technology Officer
DT
Dr. Thomas Meier
Chairman of the Board of Directors
View full Muvon Therapeutics profile